The data shows that medications such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are creating unprecedented financial pressure on plan sponsors as utilization for diabetes treatment increased 26% year-over-year
Primary endpoint: Composite of cardiovascular death, myocardial infarction, or stroke
Neurology is particularly high stakes: the EVOKE and EVOKE+ Phase 3 trials of semaglutide in early Alzheimers disease, due in 202526, will be the first large-scale cognitive readouts
doi: 10.1146/annurev-immunol-031210-101312 41 CalvanoSEXiaoWRichardsDRFelcianoRMBakerHVChoRJet al
Semaglutide helps to promote weight loss by reducing appetite, increasing satiety, and supporting overall weight management efforts
Place the Self-Injector over a fatty tissue area on the body (stomach, arm or thighs) and then gently press the one-touch button on the Self-Injector and within seconds you will be feeling refreshed and energized.